Research and Development

Showing 15 posts of 9620 posts found.

vaccination

Sanofi launches dengue immunisation program in Brazil

August 15, 2016 Research and Development, Sales and Marketing Brazil, Sanofi, Sanofi Pasteur, Vaccine, dengue, immunisation, vaccines

Sanofi has announced that it has initiated the first dengue immunisation public program in the Americas, with 500,000 individuals set …
abbvie_0

Study shows promise for Venclexta in acute myelogenous leukaemia

August 12, 2016 Research and Development, Sales and Marketing AbbVie, Genentech, Roche, Venclexta, venetoclax

A study published in Cancer Discovery, the journal of the American Association for Cancer Research, suggests that Vencletxa (venetoclax) is …
clinical_trial-web

Promising results for new type 2 diabetes management procedure

August 12, 2016 Research and Development, Sales and Marketing Fractyl, Revita, diabetes, type 2 diabetes

Fractyl Laboratories has revealed data from its first-in-human study of Revita duodenal mucosal resurfacing (Revita DMR), a new 60-minute, non-surgical …

Ashfield publishes a guide to Patient Support Programmes: Ten steps to success

August 12, 2016 Medical Communications, Research and Development, Sales and Marketing

The priorities of Pharma and healthcare organisations are better aligned as a result of the industry’s increased efforts to put …
cdc1

Number of babies born with opioid dependence has tripled in US, says CDC report

August 12, 2016 Medical Communications, Research and Development CDC, addicted, babies, opioid dependence, opioids

A new report from the Centers for Disease Control and Prevention (CDC) has highlighted a sharp increase in the number …

Novartis admits employees gave kickbacks to doctors in South Korea

August 12, 2016 Medical Communications, Research and Development Novartis, kickbacks, south korea

Novartis has confirmed that six employees in South Korea gave kickbacks to doctors, as the current and former employees face …
laboratory-testing-az

Advaxis follows up Amgen deal with Phase IIa cancer trial success

August 12, 2016 Medical Communications, Research and Development Advaxis, immunotherapy. cancer. Amgen

Advaxis, a US biotech in cancer immunotherapy development, has announced that its lead immunotherapy product axalimogene filolisbac (AXAL) has hit …
gilead-sciences

Gilead to work with Genmab on HIV targeting technology

August 12, 2016 Medical Communications, Research and Development, Sales and Marketing Genmab, Gilead, HIV, duobody

Genmab has announced that it has entered into a collaboration deal with Gilead Sciences to use the DuoBody technology platform …
shutterstock_92671375

Valeant under criminal investigation

August 11, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Philidor, Valeant, investigation

Valeant Pharmaceuticals International is currently under investigation by the US attorney’s office in Manhattan over suspicions that the firm intentionally …

FDA accepts Marathon’s Duchenne drug for priority review

August 11, 2016 Research and Development, Sales and Marketing Duchenne Muscular Dystrophy, FDA, deflazacort, marathon, marathon pharmaceuticals

Marathon Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has accepted and granted a priority review for …
chemo-web

Heron Therapeutics gets FDA approval for chemotherapy-induced nausea drug

August 11, 2016 Research and Development, Sales and Marketing FDA, chemotherapy-induced nausea, granisetron, heron therapeutics, sustol

Heron Therapeutics has announced that it has received US Food and Drug Administration (FDA) approval for Sustol (granisetron) for the …
chronos_therapeutics

Chronos Therapetics strengthens management with two new vice presidents

August 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Private biotech Chronos Therapeutics has announced two new additions to its management team; Dr Fraser Murray and Dr Timonthy Schulz-Utermoehl …
josh-smiley

New senior VP, finance at Eli Lilly

August 10, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly

Eli Lilly has announced that Joshua Smiley is set to become senior vice president, finance, and treasurer from October 1, …
china-pharmaceutical-industry

New Agilent expansion will ‘more than double’ nucleic acid API manufacture

August 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Agilent, expansion, manufacturing, oligonucleotide

Agilent Technologies is set to expand its pharmaceutical manufacturing operations with a 20-acre facility in Weld County, Colorado. The facility …
lilly_corporate_hq

Interim analysis fails to show benefits for Lilly’s abemaciclib in advanced breast cancer

August 10, 2016 Research and Development Eli Lilly, abemaciclib, breast cancer

Eli Lilly has announced that, after a pre-planned interim analysis for their Phase III MONARCH2 trial, investigators have decided to …
The Gateway to Local Adoption Series

Latest content